AbbVie Inc. is 146.8x more valuable than ALUMIS INC. by market capitalization ($402.35 B vs $2.74 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALMS | ABBV |
|---|---|---|
| Market cap | $2.74 B | $402.35 B |
| US-listed rank | #1904 | #31 |
| Revenue (latest FY) | $24.05M | $61.16B |
| Net income (latest FY) | -$243.32M | $4.23B |
| Net margin | -1011.7% | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 218 | 1,008 |
AbbVie Inc. is 146.8x more valuable than ALUMIS INC. by market capitalization ($402.35 B vs $2.74 B).
In their latest fiscal years, ALUMIS INC. reported $24.05M in revenue while AbbVie Inc. reported $61.16B.
Full pages: ALUMIS INC. and AbbVie Inc., or browse the full rankings.